Close

OPXA Financial Facts

Operating loss: -2M
General and administrative: 512.73K
See Full Income Statement

Accrued expenses: 1.1M
Total current liabilities: 2.85M
See Full Balance Sheet

Opexa Therapeutics, Inc. (OPXA) Earnings

  |   Expand Research on OPXA
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -4.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -0.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/14/16 Q316 -$0.28-$0.25 -$0.03$726.3K$720K N/A Details
8/11/16 Q216 -$0.30-$0.23 -$0.07N/A$720K N/A Details
5/12/16 Q116 -$0.31-$0.35 +$0.04$726.3K$400K N/A Details
3/15/16 Q415 N/A-$0.50 N/A N/A$720K N/A N/A N/A
11/10/15 Q315 -$0.42N/A N/A $726K$307K N/A Details
8/12/15 Q215 -$0.07-$0.08 +$0.01N/AN/A N/A Details
11/30/-1 Q115 N/A-$0.15 N/A N/A$310K N/A N/A N/A
8/14/14 Q214 -$0.15-$0.13 -$0.02$307.7K$330K N/A Details